These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6264280

  • 1. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
    Goldhirsch A, Joss RA, Cavalli F, Sonntag RW, Brunner KW.
    Med Pediatr Oncol; 1981; 9(3):205-8. PubMed ID: 6264280
    [Abstract] [Full Text] [Related]

  • 2. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
    Sierocki JS, Hilaris BS, Hopfan S, Martini N, Barton D, Golbey RB, Wittes RE.
    Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
    Drings P, Abel U, Bülzebruck H, Stiefel P, Kleckow M, Manke HG.
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S34-9. PubMed ID: 3028662
    [Abstract] [Full Text] [Related]

  • 5. [A phase II study of oral VP-16 in primary lung cancer].
    Matsui Y, Ohshima S, Kado M, Nakayama M, Shimokata K, Sakai S, Ito F, Chikata E, Hara K, Kanda T.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1801-7. PubMed ID: 2994576
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
    Kado M, Oshima S, Matsui Y, Shimokata K, Hara K, Kanda T, Shima K, Takenaka S.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study].
    Klippstein T, Graubner M, Berdel WE, Mende S, Gropp C, Diehl V, Mitrou PS.
    Onkologie; 1983 Dec; 6(6):306-11. PubMed ID: 6366676
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. cis-Platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial.
    Mitrou PS, Graubner M, Berdel WE, Mende S, Gropp C, Diehl V, Klippstein TH.
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):347-51. PubMed ID: 6538496
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cisplatin, etoposide, and mitomycin in the treatment of non-small cell carcinoma of the lung. A pilot study.
    Davis S, Tonato M, Crinò L, Colozza MA, Lubansky K, Grignani F.
    Cancer; 1986 Sep 01; 58(5):1018-9. PubMed ID: 3015372
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
    Evans WK, Feld R, Osoba D, Shepherd FA, Dill J, Deboer G.
    Cancer; 1984 Apr 01; 53(7):1461-6. PubMed ID: 6321006
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.